News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
710,040 Results
Type
Article (65043)
Company Profile (341)
Press Release (644656)
Multimedia
Podcasts (100)
Webinars (13)
Section
Business (201447)
Career Advice (2381)
Deals (33267)
Drug Delivery (98)
Drug Development (82947)
Employer Resources (147)
FDA (15980)
Job Trends (14540)
News (339863)
Policy (30620)
Tag
2024 BioCapital Digital (13)
2024 BioForest Digital (8)
2024 BioForest Standard (1)
2024 BioMidwest Digital (6)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (12)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (6)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (14)
2024 Pharm Country Digital (7)
2024 Pharm Country Standard (5)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2872)
Academic (2)
Accelerated approval (5)
Adcomms (17)
Allergies (85)
Alliances (52188)
ALS (95)
Alzheimer's disease (1462)
Antibody-drug conjugate (ADC) (136)
Approvals (15971)
Artificial intelligence (267)
Autoimmune disease (26)
Automation (14)
Bankruptcy (303)
Best Places to Work (11402)
BIOSECURE Act (18)
Biosimilars (94)
Biotechnology (237)
Bladder cancer (64)
Brain cancer (29)
Breast cancer (278)
Cancer (2207)
Cardiovascular disease (178)
Career advice (1996)
Career pathing (30)
CAR-T (155)
Cell therapy (446)
Cervical cancer (21)
Clinical research (66689)
Collaboration (872)
Compensation (488)
Complete response letters (23)
COVID-19 (2716)
CRISPR (42)
C-suite (240)
Cystic fibrosis (102)
Data (2116)
Decentralized trials (2)
Denatured (37)
Depression (51)
Diabetes (261)
Diagnostics (6336)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (42)
Drug discovery (129)
Drug pricing (91)
Drug shortages (20)
Duchenne muscular dystrophy (88)
Earnings (80006)
Editorial (39)
Employer branding (19)
Employer resources (129)
Events (110205)
Executive appointments (729)
FDA (17191)
Featured Employer (59)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (759)
Gene editing (108)
Generative AI (28)
Gene therapy (307)
GLP-1 (753)
Government (4091)
Grass and pollen (5)
Guidances (49)
Healthcare (18379)
Huntington's disease (23)
IgA nephropathy (28)
Immunology and inflammation (128)
Indications (29)
Infectious disease (2861)
Inflammatory bowel disease (142)
Inflation Reduction Act (11)
Influenza (53)
Intellectual property (95)
Interviews (431)
IPO (15908)
IRA (43)
Job creations (3602)
Job search strategy (1701)
Kidney cancer (10)
Labor market (28)
Layoffs (471)
Leadership (18)
Legal (6857)
Liver cancer (73)
Lung cancer (311)
Lymphoma (145)
Machine learning (5)
Management (49)
Manufacturing (305)
MASH (67)
Medical device (13111)
Medtech (13115)
Mergers & acquisitions (17925)
Metabolic disorders (688)
Multiple sclerosis (80)
NASH (19)
Neurodegenerative disease (101)
Neuropsychiatric disorders (29)
Neuroscience (2019)
NextGen: Class of 2025 (6388)
Non-profit (4581)
Northern California (2552)
Now hiring (27)
Obesity (362)
Opinion (244)
Ovarian cancer (75)
Pain (89)
Pancreatic cancer (82)
Parkinson's disease (155)
Partnered (23)
Patents (235)
Patient recruitment (106)
Peanut (48)
People (58071)
Pharmaceutical (80)
Pharmacy benefit managers (12)
Phase I (20906)
Phase II (29334)
Phase III (21761)
Pipeline (1159)
Policy (128)
Postmarket research (2796)
Preclinical (9418)
Press Release (72)
Prostate cancer (104)
Psychedelics (36)
Radiopharmaceuticals (264)
Rare diseases (387)
Real estate (5992)
Recruiting (57)
Regulatory (21722)
Reports (35)
Research institute (2615)
Resumes & cover letters (361)
Rett syndrome (4)
RNA editing (4)
RSV (45)
Schizophrenia (76)
Series A (136)
Series B (83)
Service/supplier (16)
Sickle cell disease (52)
Southern California (2218)
Special edition (16)
Spinal muscular atrophy (155)
Sponsored (33)
Startups (3779)
State (1)
Stomach cancer (14)
Supply chain (64)
Tariffs (20)
The Weekly (61)
United States (22438)
Vaccines (728)
Venture capitalists (35)
Weight loss (247)
Women's health (34)
Worklife (17)
Date
Today (179)
Last 7 days (552)
Last 30 days (2484)
Last 365 days (33483)
2025 (9925)
2024 (35788)
2023 (40549)
2022 (51809)
2021 (56126)
2020 (53972)
2019 (46234)
2018 (35054)
2017 (33522)
2016 (33281)
2015 (39388)
2014 (32642)
2013 (28705)
2012 (29370)
2011 (29597)
2010 (27924)
Location
Africa (922)
Alabama (59)
Alaska (6)
Arizona (191)
Arkansas (13)
Asia (42724)
Australia (7486)
California (5886)
Canada (1933)
China (517)
Colorado (258)
Connecticut (279)
Delaware (138)
Europe (97801)
Florida (869)
Georgia (197)
Idaho (45)
Illinois (499)
India (26)
Indiana (287)
Iowa (8)
Japan (160)
Kansas (107)
Kentucky (22)
Louisiana (12)
Maine (64)
Maryland (880)
Massachusetts (4464)
Michigan (229)
Minnesota (388)
Mississippi (1)
Missouri (79)
Montana (30)
Nebraska (25)
Nevada (58)
New Hampshire (61)
New Jersey (1682)
New Mexico (31)
New York (1691)
North Carolina (1019)
North Dakota (7)
Northern California (2552)
Ohio (206)
Oklahoma (14)
Oregon (33)
Pennsylvania (1279)
Puerto Rico (9)
Rhode Island (29)
South America (1202)
South Carolina (22)
Southern California (2218)
Tennessee (94)
Texas (871)
Utah (174)
Virginia (151)
Washington D.C. (59)
Washington State (560)
West Virginia (2)
Wisconsin (59)
710,040 Results for "janssen research and development".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SMSbiotech Establishes a Cooperative Research and Development Agreement with the U.S. Army Medical Research Institute of Chemical Defense
April 22, 2025
·
1 min read
Press Releases
Johnson & Johnson Celebrates Innovation in Regulated RNA and Protein Degradation with 2024 Dr. Paul Janssen Award for Biomedical Research
September 26, 2024
·
5 min read
Press Releases
Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas
April 16, 2025
·
5 min read
Press Releases
NUS researchers develop microneedle technology to accelerate diabetic wound healing
March 26, 2025
·
5 min read
Pharm Country
Janssen to Highlight Latest Research from Nipocalimab Clinical Development Program to Address Unmet Need in Myasthenia Gravis at AANEM 2023 Meeting
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that 20 company-sponsored presentations from its nipocalimab and autoantibody diseases research program will be showcased at the 2023 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Meeting from November 1-4 in Phoenix, Arizona.
October 16, 2023
·
12 min read
Business
Illumina expands collaboration with Janssen to advance molecular residual disease cancer test
Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has signed an agreement with Janssen Research & Development, LLC (Janssen).
January 5, 2024
·
3 min read
Press Releases
Children’s Hospital of Philadelphia Researchers Develop Cell Atlas to Uncover Significant Shifts in the Neuroblastoma Tumor Microenvironment
April 14, 2025
·
5 min read
Genetown
Elektrofi and Janssen Biotech Enter Worldwide Collaboration and License Agreement to Exclusively Develop up to Five Programs Utilizing Elektrofi’s Formulation Technology
Elektrofi, Inc. announced that it has entered a multi-target worldwide research collaboration and license agreement with Janssen Biotech, Inc., a Johnson & Johnson company.
January 3, 2024
·
2 min read
Press Releases
SpyGlass Pharma Appoints Chetan Pujara, Ph.D., as Chief Research & Development Officer
March 28, 2025
·
2 min read
Press Releases
Sumitomo Pharma America enters into a Cooperative Research and Development Agreement with the National Cancer Institute to Advance Clinical Understanding of Enzomenib
April 14, 2025
·
5 min read
1 of 71,004
Next
